Showing results (191-200 of 281) with videos related to
Sort By:
Pageof 29
Circulation. Cardiovascular Interventions|August 13, 2017
Cangrelor in Older Patients Undergoing Percutaneous Coronary Intervention: Findings From CHAMPION PHOENIXMatthew A Cavender, Deepak L Bhatt, Gregg W Stone, et al.JACC. Cardiovascular Interventions|October 25, 2023
1-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From the EXPAND G4 StudyRalph Stephan von Bardeleben, Paul Mahoney, M Andrew Morse, et al.Circulation|January 15, 2016
Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention: Insights From the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION PHOENIX) TrialMichelle L O'Donoghue, Deepak L Bhatt, Gregg W Stone, et al.Circulation|August 3, 2016
Consistent Reduction in Periprocedural Myocardial Infarction With Cangrelor as Assessed by Multiple Definitions: Findings From CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition)Matthew A Cavender, Deepak L Bhatt, Gregg W Stone, et al.JAMA Cardiology|December 1, 2016
Evaluation of Ischemic and Bleeding Risks Associated With 2 Parenteral Antiplatelet Strategies Comparing Cangrelor With Glycoprotein IIb/IIIa Inhibitors: An Exploratory Analysis From the CHAMPION TrialsMuthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.Journal of the American Heart Association|November 22, 2024
Racial and Ethnic Disparities in the Use and Outcomes With WATCHMAN FLX: A SURPASS Analysis of the NCDR Left Atrial Appendage Occlusion RegistryOluseun O Alli, Jalaj Garg, Brian C Boursiquot, et al.Circulation|December 21, 2018
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.Circulation. Cardiovascular Interventions|November 3, 2016
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 UpdateDominick J Angiolillo, Shaun G Goodman, Deepak L Bhatt, et al.Journal of the American College of Cardiology|January 14, 2017
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary InterventionMuthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 9, 2017
Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trialsMuthiah Vaduganathan, Robert A Harrington, Gregg W Stone, et al.Pageof 29